Mitotech's profile picture. Mitotech’s business is centered around rapid development of breakthrough pharmaceutical products based on mitochondrially addressed antioxidant SkQ1.

Mitotech

@Mitotech

Mitotech’s business is centered around rapid development of breakthrough pharmaceutical products based on mitochondrially addressed antioxidant SkQ1.

Please join us for the Mitotech S.A. KOL Webinar on Visomitin®: A Potential Treatment For Dry Eye Disease featuring Dr. Sheppard, Dr. Karpecki, and Mr. Ousler. A live Q&A session will follow. Register here: lifesci.events/Mitotech

Mitotech's tweet image. Please join us for the Mitotech S.A. KOL Webinar on Visomitin®: A Potential Treatment For Dry Eye Disease featuring Dr. Sheppard, Dr. Karpecki, and Mr. Ousler. A live Q&A session will follow. Register here: lifesci.events/Mitotech

On March 11 Mitotech will be presenting its VISTA-2 Dry Eye study results and ophthalmology pipeline at the OIS Dry Eye Innovation Showcase! Hope to see you then! #OIS2021

Mitotech's tweet image. On March 11 Mitotech will be presenting its VISTA-2 Dry Eye study results and ophthalmology pipeline at the OIS Dry Eye Innovation Showcase! Hope to see you then! #OIS2021

Natalia Perekhvatova, CEO of Mitotech, S.A., is presenting at the 13th Annual Biotech Showcase Digital 2021 Conference this week. The conference is virtual and is occurring in parallel with the J.P. Morgan 39th Annual Healthcare Conference 2021.


This account does not follow anyone
Loading...

Something went wrong.


Something went wrong.